or a combination of both depending on the patient and surgeon factors. Influencing factors may include the extent of the primary disease, peripheral diseases, cost of treatment, and patient preference. [6, 7] Osteocutaneous free flaps are commonly utilized for mandibular reconstruction as they can be shaped into the portion of the mandible that has been resected and present adequate osseous volume for the placement of dental implants. These free flaps have shown long-term stability and are considered the "workhorse" for mandibular reconstruction. [5] However, in patients contraindicated for osteocutaneous free flaps such as patients with renal insufficiency, cardiopulmonary failure, severe osteoporosis, or other complicating comorbidities, a fasciocutaneous free flap can be considered. [8, 9] Fasciocutaneous free flaps are selected based on the planned surgical defect and are intended to restore facial contours without the free transfer of bone. Following the use of a fasciocutaneous free flap for the reconstruction of an oral defect, the prospect of intraoral rehabilitation can be technically demanding due to postoperative altered anatomy and the resulting sensory deficits (i.e., loss of musculature and motor coordination of the residual mandible). To compensate for this, a mandibular resection prosthesis with or without a guide flange can be fabricated. [10] A guide-flange resection prosthesis can assist the patient to achieve a maximum intercuspal position and thus assist in mastication. [11] [12] [13] Mandibular resection prostheses for patients with discontinuity defects of the mandible require commitment from both the patient and the provider to fabricate and at present, there is a paucity of information regarding the effort required for the fabrication of such prostheses. The purpose of this study was to retrospectively review a consecutive series of patients reconstructed with fasciocutaneous free flaps who had mandibular resection prostheses fabricated during a 17-year period at a tertiary cancer center and to review treatment concepts for the management of such patients.
MATERIALS AND METHODS
A retrospective review was completed (IRB #16-1132) of patients who underwent fasciocutaneous free-flap reconstruction of the mandible as well as successful fabrication of a mandibular resection prosthesis at a tertiary cancer center between 2000 and 2017. Pediatric patients (under 18-year-old) and patients who had mandibular continuity (native or reconstructed) were excluded from this study. Patient records were reviewed to obtain patient demographics, tumor data, treatment data, and mandibular resection prosthesis interval data. To better quantify immediate postoperative follow-up after prosthesis delivery, the number of appointments during the first 90 days in 30-day interval were recorded. All the data was compiled and analyzed using Microsoft Excel (Microsoft Corp., Redmond, WA, USA).
RESULTS
During the study, 21 consecutive patients who had fasciocutaneous free flaps to reconstruct mandibular defects, as well as mandibular resection prostheses, were identified. Seventeen (81%) patients were male and four (19%) patients were female, with an average age of 66 years (range 46-84 years). Patient tumor and treatment data is presented in Table 1 . About 76% (n = 16) of patients had a primary diagnosis of squamous cell carcinoma. Approximately 53% of patients (n = 11) had higher staged tumors (T3-T4), and approximately 33% of patients (n = 7) had nodal involvement.
The two most commonly used fasciocutaneous free flaps were pectoralis major myocutaneous free flaps 43% (n = 9) and rectus abdominis free flaps 38% (n = 8). Radial forearm free flaps, anterolateral thigh free flaps, and latissimus dorsi free flaps were used in the remaining patients 19% (n = 4).
The time to mandibular resection prosthesis delivery following primary surgery, as well as the time from the mandibular resection prosthesis delivery to last dental follow-up, is presented in Table 2 . Following prosthesis delivery, the median number of follow-up appointments from 0 to 30 days was 1 visit (range 0-3), and the median number of follow-up appointments from 0 to 90 days was 2 visits (range 0-4).
DISCUSSION
This study reports a series of 21 patients with oral cancer, who underwent segmental mandibulectomy with reconstruction followed by fabrication of mandibular resection prosthesis. The goal of this treatment is to both reconstruct the surgical defect giving the superficial shape to the mandible as well as improve the quality of life of the patient by providing esthetic and functional mandibular resection prosthesis. This review reports the timing of care as well as the follow-up required postdelivery of the mandibular resection prosthesis. The median time to deliver the prosthesis from the time of surgery was 9 months. Following the delivery of the prosthesis, patients presented with a median follow-up of 1 visit within Figure 1 ], it is not uncommon for the patient to experience deviation of the residual mandible toward the surgical defect [14] [ Figure 2 ]. This will create a malocclusion as the maxillary and mandibular arches will no longer be aligned and the patient will be unable to repeatedly achieve maximum intercuspation, and hence impair deglutition. Preoperative multidisciplinary planning with the surgical team may assist in assuring that mobility of the residual mandible is maintained and that adequate interocclusal, as well as vestibular space, is maintained for the fabrication of resection prosthesis. If the patient can be manually positioned into maximum intercuspation after completion of their oncologic treatment, the patient may be a candidate for the fabrication of mandibular resection prosthesis with a guide flange. Such prosthesis is retained by the remaining mandibular dentition and contains a vertical flange, usually either made of acrylic or metal. The flange engages the buccal surfaces of the maxillary dentition and on closure will guide the dentition into maximum intercuspation [10] [ Figure 3 ]. The goal of such a prosthesis is to improve masticatory function by enabling the patient to repeatedly achieve a position, in which occlusal contacts can be generated. [11, 15] These prostheses can be reliably fabricated by practitioners knowledgeable in the principles of removable prosthodontics often without the need for additional surgical procedures.
There were several limitations in this study. First, there is a relatively small group of patients in this cohort, as fasciocutaneous reconstruction is not the mainstay of mandibular rehabilitation at our tertiary cancer center. Collaborative studies from other centers would be helpful to better understand the generalizability of the results. In addition, this study was limited to patients that had mandibular resection prostheses fabricated at the Dental Service of Memorial Sloan Kettering Cancer Center. As a result, additional patients who had resection prostheses fabricated elsewhere were not included in this cohort. Moreover, as this was a retrospective review, patient-reported outcomes and prosthesis function data were unavailable for a review. Future studies may be able to assess the patient and physician perception of prosthesis performance.
CONCLUSIONS
Oral rehabilitation with mandibular resection prostheses with or without guide flanges following segmental mandibulectomy with fasciocutaneous free-flap reconstruction is an attainable treatment goal for the oncologic patient. Such prostheses, if collaboratively planned, may be reliably fabricated by the dental practitioner. Reviewing the proposed course of care is helpful for patient management before proceeding with prosthetic oral rehabilitation.
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